公司資料
Bicycle Therapeutics 股價、新聞與催化劑
- 股票代碼:
- BCYC
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United Kingdom with U
股票表現
4.00 USD (+2.56%)
收盤價
最後更新: 2026年8月17日
300M USD
市值
股價為何變動
As of Aug 17, 2026, BCYC closed up 2.56% at $4.00. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Bicycle Therapeutics is a precision-oncology company focused on bicyclic peptide therapeutics and targeted cancer biology. Its platform seeks to pair selectivity with tumor targeting.
所在地與產業分類
Headquartered in the United Kingdom with U.S. market exposure and listed on NASDAQ as an ADR, Bicycle is a global oncology biotech.
商業模式特徵
The company depends on clinical data, platform validation, and the possibility of building a differentiated targeted-cancer franchise.
生技產業定位
Bicycle is a high-quality platform oncology name whose valuation hinges on translational and clinical progress.
未來催化劑
- Bicycle Therapeutics's catalysts are BT8009 and BT5528, with oncology data driving whether the platform can still justify premium expectations. The next readout matters a lot because the platform story is still being judged.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。